Treatment of Advanced and Metastatic NSCLC: The Rise of the Personalized Approach to Patients

Benjamin Levy, MD


September 29, 2022

Benjamin Levy, MD, speculates on the development of a more personalized practice of medicine in the treatment of advanced non–small cell lung cancer (NSCLC) while offering advice to clinicians just launching their careers.

Dr Levy notes the daunting, yet inspiring, challenges that stem from such a change, and especially the great complexity that accompanies it. The drive to attend to the particularities of individual patients involves the use of multiple angles of analysis, all of which must be coordinated in a multidisciplinary fashion in order to provide the best care possible.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.